New patent for Alkermes Inc drug LYBALVI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for LYBALVI
Annual Drug Patent Expirations for LYBALVI

Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

LYBALVI drug price trends.

This drug has sixty-three patent family members in twenty-seven countries.

The generic ingredient in LYBALVI is olanzapine; samidorphan l-malate. One supplier is listed for this compound. Additional details are available on the olanzapine; samidorphan l-malate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top